Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Product revenue, net $ 12,165 $ 20,796
Other revenue 48 2,500
Total revenue 12,213 23,296
Operating expenses    
Cost of goods sold - product revenue 6,449 8,203
Research and development 2,033 1,266
Selling, general and administrative 13,292 14,715
Total operating expenses 21,774 24,184
Loss from operations (9,561) (888)
Other expense (income)    
Interest income (122) (3)
Interest expense 650 389
Foreign exchange transaction losses 47  
Total other expense (income) 575 386
Loss before income taxes (10,136) (1,274)
Income tax expense   104
Net Loss $ (10,136) $ (1,378)
Net loss per common share:    
Basic and diluted $ (0.57) $ (0.08)
Basic and diluted $ (0.57) $ (0.08)
Weighted average number of common shares:    
Basic and diluted 17,807,194 17,318,344
Basic and diluted 17,807,194 17,318,344